BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 10356283)

  • 1. P450BM-3: absolute configuration of the primary metabolites of palmitic acid.
    Truan G; Komandla MR; Falck JR; Peterson JA
    Arch Biochem Biophys; 1999 Jun; 366(2):192-8. PubMed ID: 10356283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dithionite-supported hydroxylation of palmitic acid by cytochrome P450BM-3.
    Fang X; Halpert JR
    Drug Metab Dispos; 1996 Nov; 24(11):1282-5. PubMed ID: 8937865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reconstitution of the fatty acid hydroxylase activity of cytochrome P450BM-3 utilizing its functional domains.
    Sevrioukova I; Truan G; Peterson JA
    Arch Biochem Biophys; 1997 Apr; 340(2):231-8. PubMed ID: 9143326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thr268 in substrate binding and catalysis in P450BM-3.
    Truan G; Peterson JA
    Arch Biochem Biophys; 1998 Jan; 349(1):53-64. PubMed ID: 9439582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of substrates at the surface of P450s can greatly enhance substrate potency.
    Hegde A; Haines DC; Bondlela M; Chen B; Schaffer N; Tomchick DR; Machius M; Nguyen H; Chowdhary PK; Stewart L; Lopez C; Peterson JA
    Biochemistry; 2007 Dec; 46(49):14010-7. PubMed ID: 18004886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
    Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
    Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxygen activation by cytochrome P450BM-3: effects of mutating an active site acidic residue.
    Yeom H; Sligar SG
    Arch Biochem Biophys; 1997 Jan; 337(2):209-16. PubMed ID: 9016815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of inhibitor-bound P450BM-3 reveals open conformation of substrate access channel.
    Haines DC; Chen B; Tomchick DR; Bondlela M; Hegde A; Machius M; Peterson JA
    Biochemistry; 2008 Mar; 47(12):3662-70. PubMed ID: 18298086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The kinetic and spectral characterization of the E. coli-expressed mammalian CYP4A7: cytochrome b5 effects vary with substrate.
    Loughran PA; Roman LJ; Miller RT; Masters BS
    Arch Biochem Biophys; 2001 Jan; 385(2):311-21. PubMed ID: 11368012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are branched chain fatty acids the natural substrates for P450(BM3)?
    Cryle MJ; Espinoza RD; Smith SJ; Matovic NJ; De Voss JJ
    Chem Commun (Camb); 2006 Jun; (22):2353-5. PubMed ID: 16733577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obligatory intermolecular electron-transfer from FAD to FMN in dimeric P450BM-3.
    Kitazume T; Haines DC; Estabrook RW; Chen B; Peterson JA
    Biochemistry; 2007 Oct; 46(42):11892-901. PubMed ID: 17902705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency.
    Huang WC; Westlake AC; Maréchal JD; Joyce MG; Moody PC; Roberts GC
    J Mol Biol; 2007 Oct; 373(3):633-51. PubMed ID: 17868686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450BM-3 (CYP102): regiospecificity of oxidation of omega-unsaturated fatty acids and mechanism-based inactivation.
    Shirane N; Sui Z; Peterson JA; Ortiz de Montellano PR
    Biochemistry; 1993 Dec; 32(49):13732-41. PubMed ID: 8257708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imidazolyl carboxylic acids as mechanistic probes of flavocytochrome P-450 BM3.
    Noble MA; Quaroni L; Chumanov GD; Turner KL; Chapman SK; Hanzlik RP; Munro AW
    Biochemistry; 1998 Nov; 37(45):15799-807. PubMed ID: 9843385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How do substrates enter and products exit the buried active site of cytochrome P450cam? 1. Random expulsion molecular dynamics investigation of ligand access channels and mechanisms.
    Lüdemann SK; Lounnas V; Wade RC
    J Mol Biol; 2000 Nov; 303(5):797-811. PubMed ID: 11061976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The highly stereoselective oxidation of polyunsaturated fatty acids by cytochrome P450BM-3.
    Capdevila JH; Wei S; Helvig C; Falck JR; Belosludtsev Y; Truan G; Graham-Lorence SE; Peterson JA
    J Biol Chem; 1996 Sep; 271(37):22663-71. PubMed ID: 8798438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatty acid monooxygenation by P450BM-3: product identification and proposed mechanisms for the sequential hydroxylation reactions.
    Boddupalli SS; Pramanik BC; Slaughter CA; Estabrook RW; Peterson JA
    Arch Biochem Biophys; 1992 Jan; 292(1):20-8. PubMed ID: 1727637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cobaltocene-mediated catalytic monooxygenation using holo and heme domain cytochrome P450 BM3.
    Udit AK; Arnold FH; Gray HB
    J Inorg Biochem; 2004 Sep; 98(9):1547-50. PubMed ID: 15337607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing the structure of the linker connecting the reductase and heme domains of cytochrome P450BM-3 using site-directed mutagenesis.
    Govindaraj S; Poulos TL
    Protein Sci; 1996 Jul; 5(7):1389-93. PubMed ID: 8819171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
    Roitel O; Scrutton NS; Munro AW
    Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.